Products

Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.

Connect With Us

+63 919 076 9100

Targeted Therapy (141)

Quick filters: Solid Tumour Hematologic Both Name A-Z Name Z-A

Therapeutic Areas

Sort by

Clear all filters

Molecule	Drug Class / Mechanism	Oncology Type	Inquiry
Triciribine	AKT Inhibitor	Solid Tumour
Molecule Triciribine Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism AKT Inhibitor
Bozitinib	MET Inhibitor	Solid Tumour
Molecule Bozitinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism MET Inhibitor
Glumetinib	MET Inhibitor	Solid Tumour
Molecule Glumetinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism MET Inhibitor
Elzovantinib	MET Inhibitor	Solid Tumour
Molecule Elzovantinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism MET Inhibitor
Bavdegalutamide	Androgen Receptor Degrader (PROTAC)	Solid Tumour (Prostate)
Molecule Bavdegalutamide Therapeutic Category Targeted Therapy Oncology Type Solid Tumour (Prostate) Drug Class / Mechanism Androgen Receptor Degrader (PROTAC)
ARV-110 (Bavdegalutamide)	Androgen Receptor Degrader (PROTAC)	Solid Tumour (Prostate)
Molecule ARV-110 (Bavdegalutamide) Therapeutic Category Targeted Therapy Oncology Type Solid Tumour (Prostate) Drug Class / Mechanism Androgen Receptor Degrader (PROTAC)
ARV-471 (Vepdegestrant)	Androgen Receptor Degrader (PROTAC)	Solid Tumour (Prostate)
Molecule ARV-471 (Vepdegestrant) Therapeutic Category Targeted Therapy Oncology Type Solid Tumour (Prostate) Drug Class / Mechanism Androgen Receptor Degrader (PROTAC)
CC-94676	Androgen Receptor Degrader (PROTAC)	Solid Tumour (Prostate)
Molecule CC-94676 Therapeutic Category Targeted Therapy Oncology Type Solid Tumour (Prostate) Drug Class / Mechanism Androgen Receptor Degrader (PROTAC)
Masofaniten	Androgen Receptor Degrader (PROTAC)	Solid Tumour (Prostate)
Molecule Masofaniten Therapeutic Category Targeted Therapy Oncology Type Solid Tumour (Prostate) Drug Class / Mechanism Androgen Receptor Degrader (PROTAC)

Triciribine Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism AKT Inhibitor
Bozitinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism MET Inhibitor
Glumetinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism MET Inhibitor
Elzovantinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism MET Inhibitor
Bavdegalutamide Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour (Prostate) Drug Class / Mechanism Androgen Receptor Degrader (PROTAC)
ARV-110 (Bavdegalutamide) Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour (Prostate) Drug Class / Mechanism Androgen Receptor Degrader (PROTAC)
ARV-471 (Vepdegestrant) Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour (Prostate) Drug Class / Mechanism Androgen Receptor Degrader (PROTAC)
CC-94676 Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour (Prostate) Drug Class / Mechanism Androgen Receptor Degrader (PROTAC)
Masofaniten Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour (Prostate) Drug Class / Mechanism Androgen Receptor Degrader (PROTAC)

‹ 1 … 10 11 12 ›